BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17574314)

  • 21. [Levels of bactericidal antibodies against meningococcus C after vaccination in 2- to 6-year-old children in Andalusia].
    Delgado Torralbo E; Vazquez Moreno JA; García León J; González Enríquez J; Martínez Navarro F; Berrón Morato S; Mayoral Cortés JM; Rubin Gómez MA; Méndez Martínez C; Cortés Majó M; Chaves Caballero M; Bernal González ML
    Rev Esp Salud Publica; 2000; 74(4):433-44. PubMed ID: 11031854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults.
    Kshirsagar N; Mur N; Thatte U; Gogtay N; Viviani S; Préziosi MP; Elie C; Findlow H; Carlone G; Borrow R; Parulekar V; Plikaytis B; Kulkarni P; Imbault N; LaForce FM
    Vaccine; 2007 Sep; 25 Suppl 1():A101-7. PubMed ID: 17532101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal surrogates of protection--serum bactericidal antibody activity.
    Borrow R; Balmer P; Miller E
    Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis.
    Stoehr GA; Luecken J; Zielen S; Eber SW; Borrow R; Rose MA
    Br J Surg; 2008 Apr; 95(4):466-71. PubMed ID: 18161897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term seroprotection after an adolescent booster meningococcal serogroup C vaccination.
    de Whalley PC; Snape MD; Plested E; Thompson B; Nuthall E; Omar O; Borrow R; Pollard AJ
    Arch Dis Child; 2013 Sep; 98(9):686-91. PubMed ID: 23853000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of conjugate meningococcus C vaccine in pediatric solid organ transplant recipients.
    Zlamy M; Elias J; Vogel U; Frosch M; Jeller V; Cortina G; Jungraithmayr T; Prelog M
    Vaccine; 2011 Aug; 29(37):6163-6. PubMed ID: 21718742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.
    Trotter CL; Borrow R; Findlow J; Holland A; Frankland S; Andrews NJ; Miller E
    Clin Vaccine Immunol; 2008 Nov; 15(11):1694-8. PubMed ID: 18827191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.
    Chandramohan D; Hodgson A; Coleman P; Baiden R; Asante K; Awine E; Owusu-Agyei S; Boutriau D; Nelson CB; Greenwood B
    Vaccine; 2007 Sep; 25 Suppl 1():A83-91. PubMed ID: 17521782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of the long-term antibody response after meningococcal C vaccination in patients with juvenile idiopathic arthritis: a retrospective cohort study.
    Stoof SP; Heijstek MW; Sijssens KM; van der Klis F; Sanders EA; Teunis PF; Wulffraat NM; Berbers GA
    Ann Rheum Dis; 2014 Apr; 73(4):728-34. PubMed ID: 23505231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.
    Frasch CE; Borrow R; Donnelly J
    Vaccine; 2009 Jun; 27 Suppl 2():B112-6. PubMed ID: 19464093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avidity of serogroup A meningococcal IgG antibodies after immunization with different doses of a tetravalent A/C/Y/W135 polysaccharide vaccine.
    Bårnes GK; Naess LM; Rosenqvist E; Guerin PJ; Caugant DA;
    Scand J Immunol; 2011 Jul; 74(1):87-94. PubMed ID: 21332570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
    Cui XL; Wu X; Li MQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
    [No Abstract]   [Full Text] [Related]  

  • 34. Meningococcal A vaccination response is enhanced by acute stress in men.
    Edwards KM; Burns VE; Adkins AE; Carroll D; Drayson M; Ring C
    Psychosom Med; 2008 Feb; 70(2):147-51. PubMed ID: 18256346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meningococcal polysaccharide vaccine failure in a patient with C7 deficiency and a decreased anti-capsular antibody response.
    Keiser PB; Broderick M
    Hum Vaccin Immunother; 2012 May; 8(5):582-6. PubMed ID: 22634438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural and vaccine-induced immunity to Neisseria meningitidis serogroup C in asplenic patients with β-thalassemia.
    Spoulou V; Tzanakaki G; Lekka S; Chouliaras G; Ladis V; Theodoridou M
    Vaccine; 2011 Jun; 29(27):4435-8. PubMed ID: 21497638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003.
    Soriano-Gabarró M; Toé L; Tiendrebeogo SR; Nelson CB; Dabal M; Djingarey MH; Plikaytis B; Rosenstein N;
    Vaccine; 2007 Sep; 25 Suppl 1():A92-6. PubMed ID: 17517451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.
    Jokhdar H; Borrow R; Sultan A; Adi M; Riley C; Fuller E; Baxter D
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):83-8. PubMed ID: 14715549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus ointment does not affect the immediate response to vaccination, the generation of immune memory, or humoral and cell-mediated immunity in children.
    Hofman T; Cranswick N; Kuna P; Boznanski A; Latos T; Gold M; Murrell DF; Gebauer K; Behre U; Machura E; Olafsson J; Szalai Z;
    Arch Dis Child; 2006 Nov; 91(11):905-10. PubMed ID: 16798785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children.
    Granoff DM; Morgan A; Welsch JA
    Vaccine; 2005 Jul; 23(34):4307-14. PubMed ID: 15921829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.